Search results
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 6 days agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
...NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation...
NewMediaWire via Yahoo Finance· 1 day ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen, ...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
AOL· 4 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update their formulas for fall doses, in an attempt to target ...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News· 4 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
FDA recommends COVID jab manufacturers update formulas to combat new strain
BizPac Review· 4 days agoA new strain of COVID has prompted recommendations for vaccine companies to update their formulas in anticipation of cases in the fall. The U.S. Food and ...
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun· 5 days agoA new COVID-19 variant called KP.3 is on the rise in the United States and has been detected in...
Gateway - Quartz
Quartz· 1 day agoA new study found that Novo Nordisk’s nearly $1,000 per month diabetes medication Ozempic can be produced for less than $5 a month. Novo Nordisk and Johnson & Johnson both announced billion-dollar ...
Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Short Interest Update
ETF DAILY NEWS· 2 days agoBasilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report) was the target of a large drop in short interest in the month of May. As of May 31st, there was short interest totalling 74,900 shares ...
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 5 days agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
Covid cases rising in LA County, California as new subvariants make mark
Fairfield-Suisun Daily Republic· 7 days agoCalifornia's Covid numbers are on the rise thanks, in part, to new subvariants, suggesting an...